openPR Logo
Press release

United States Fetal Bovine Serum Market with CAGR of 5.3% during 2024-2031 - Exclusive Report by DatamIntelligence

10-10-2025 01:31 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Fetal Bovine Serum Market

Fetal Bovine Serum Market

"Fetal Bovine Serum Market size is estimated to reach at a high CAGR 5.3% during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/fetal-bovine-serum-market?sp

United States: Recent Industry Developments

✅ In September 2025, Thermo Fisher Scientific launched a premium-grade Fetal Bovine Serum optimized for stem cell and regenerative medicine research. The serum offers consistent growth performance and enhanced cell viability.

✅ In August 2025, Gibco expanded its FBS production facility in Indiana with a $50 million investment to meet increasing demand from biotech and cell therapy companies. The expansion improves supply stability for U.S. researchers.

✅ In July 2025, Sigma-Aldrich introduced a new animal-free FBS alternative for lab-scale cell culture, supporting ethical sourcing and reducing reliance on animal-derived products.

✅ In June 2025, Corning Life Sciences implemented AI-driven quality control for FBS batches, enhancing traceability, reproducibility, and compliance for research applications in the U.S.

Japan: Recent Industry Developments

✅ In September 2025, Kanto Chemical launched a high-purity FBS product for stem cell and regenerative medicine applications, emphasizing batch-to-batch consistency.

✅ In August 2025, DS Pharma Biomedical invested in expanding its FBS processing and storage facilities to support Japan's growing cell therapy and biopharmaceutical research sectors.

✅ In July 2025, Nacalai Tesque introduced an animal-free FBS substitute for laboratory use, promoting ethical and sustainable research practices in Japan.

✅ In June 2025, FUJIFILM Wako Pure Chemical Industries implemented advanced quality control systems for FBS production, enhancing reproducibility and research reliability across Japanese laboratories.

Fetal Bovine Serum Market: Drivers

The fetal bovine serum (FBS) market is witnessing strong growth due to its critical role as a supplement in cell culture media for biopharmaceutical research, vaccine production, and regenerative medicine. FBS provides essential growth factors, hormones, and nutrients that support the proliferation and maintenance of mammalian cells. Rising demand for biopharmaceuticals, including monoclonal antibodies and gene therapies, is driving the need for high-quality cell culture reagents. Advances in biotechnology and increasing investment in research and development are further boosting market adoption. Strict quality standards and regulatory compliance ensure reliability, safety, and reproducibility in scientific research and industrial applications.

Expansion of academic and industrial research activities in life sciences is contributing to the growing consumption of FBS globally. Increasing focus on personalized medicine, stem cell research, and tissue engineering is driving demand for consistent and high-performance serum products. Technological innovations in serum processing, testing, and filtration enhance product quality and traceability. Alternative serum formulations and synthetic substitutes are emerging but FBS remains the preferred choice due to its unmatched performance. With rising investments in biotechnology and life sciences, the fetal bovine serum market is expected to maintain steady growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/fetal-bovine-serum-market?sp

Fetal Bovine Serum Market: Major Players

Bovogen, Atlas Biologicals, Inc., GE Healthcare, Cytiva, HiMedia Laboratories, Merck KgaA, PAN-Biotech, R&D Systems Inc., Rocky Mountain Biologicals, TCS Biosciences Ltd, Thermo Fisher Scientific

Segment Covered in the Fetal Bovine Serum Market:

➥ By Product: Stem Cell, Charcoal Stripped, Dialyzed Fetal Bovine Serum, Others

➥ By Application: Biopharmaceuticals, Cell Culture Media, Human & Animal Vaccine Production, Others

➥ By End-user: Research & Academic Institutes, Biotechnology & Pharmaceutical Industry, Others

Research Process:

Both primary and secondary data sources have been used in the Fetal Bovine Serum Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Fetal Bovine Serum Market Research Industry:

➠ Who leads the Fetal Bovine Serum industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Fetal Bovine Serum market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Fetal Bovine Serum market growth?
➠ What are the dominant sales and distribution strategies in the Fetal Bovine Serum industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=fetal-bovine-serum-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Fetal Bovine Serum Market with CAGR of 5.3% during 2024-2031 - Exclusive Report by DatamIntelligence here

News-ID: 4218097 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Marfan Syndrome Treatment Market valuation $312.6 million by 2031 - Exclusive Report by DatamIntelligence
Marfan Syndrome Treatment Market valuation $312.6 million by 2031 - Exclusive Re …
"Global Marfan Syndrome Treatment Market reached US$ 203.5 million in 2023 and is expected to reach US$ 312.6 million by 2031, growing at a CAGR of 5.6% during the forecast period 2024-2031." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/marfan-syndrome-treatment-market?sp United States: Recent Industry Developments ✅ In September 2025, Roche launched a clinical trial for a new angiotensin receptor-neprilysin inhibitor targeting aortic dilation
United States Menopause Treatment Market with CAGR of 8.8% during 2023-2030 - Exclusive Report by DatamIntelligence
United States Menopause Treatment Market with CAGR of 8.8% during 2023-2030 - Ex …
"Menopause Treatment Market is expected to grow at a CAGR of 8.8% during the forecasting period 2023-2030." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/menopause-treatment-market?sp United States: Recent Industry Developments ✅ In September 2025, Pfizer launched an oral therapy targeting moderate-to-severe vasomotor symptoms in menopausal women. The treatment improves quality of life and provides a non-hormonal alternative. ✅ In August 2025, Amgen initiated a
United States Medical Billing Market to Reach USD 339.31 Billion by 2033, Driven by Healthcare Digitalization and AI Automation | DataM Intelligence
United States Medical Billing Market to Reach USD 339.31 Billion by 2033, Driven …
The global Medical Billing Market reached USD 122.21 billion in 2024 and is projected to reach USD 339.31 billion by 2033, growing at a CAGR of 12.1% during the forecast period 2025-2033, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, The Centers for Medicare & Medicaid Services (CMS) implemented new automated billing codes for telehealth services, streamlining reimbursement processes. ✅ In August 2025, A major US healthcare
United States 23-Valent Pneumococcal Polysaccharide Vaccine Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States 23-Valent Pneumococcal Polysaccharide Vaccine Market 2025 | Growth …
Market Size and Growth The Global "23-valent Pneumococcal Polysaccharide Vaccine Market" is estimated to reach at a high CAGR during the forecast period (2023-2030). Key Development: United States: Recent Industry Developments ✅ In March 2025, AIM Vaccine completed Phase III clinical trials for its 23-valent pneumococcal polysaccharide vaccine (PPSV23) and plans to submit a pre-application for market registration, aiming to capture a significant share of the adult vaccine market. ✅ In September 2024, Sinovac developed

All 5 Releases


More Releases for Fetal

Global Fetal And Maternal Monitor Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Fetal And Maternal Monitor market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Growing awareness of maternal and fetal health, particularly in developing nations, is driving the market for
Fetal Monitoring: Top Companies Revenue Analysis
The Fetal Monitoring Market is expected to register a CAGR of 6.93% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Brochure @ https://www.theinsightpartners.com/sample/TIPMD00002260/?utm_source=OpenPR&utm_medium=10432 The List of Companies 1. NEOVENTA MEDICAL AB 2. NATUS MEDICAL INCORPORATED 3. SIEMENS HEALTHCARE 4. GENERAL ELECTRIC COMPANY 5. ANALOGIC CORPORATION 6. FUJIFILM SONOSITE 7. PHILIPS HEALTHCARE 8. OSI SYSTEMS, INC 9. MEDTRONIC PLC 10. GETINGE GROUP Fetal Monitoring Market Segmentation Product Product • Ultrasound Devices • Fetal Monitors • Telemetry
[Latest] Fetal Monitoring Systems Market : An Overview
The ""Fetal Monitoring Systems Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Fetal Monitoring Systems Market, 2024-2031 Verified Market Research's most recent report, ""Fetal Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,""
2022 Fetal Monitoring Market Analysis, Industry Demand, Size, Sales, Trends Oppo …
The report covers current market growths including market enlargement, partnerships & collaborations, mergers & acquisitions, and new product launches. Moreover, the study includes an absolute financial study, SWOT profile, business policies, newly launched products & services, and a business summary of the market players. This study stakeholders and new business entrants to understand the present market trends and convey new business tactics. It also outlines the strategies adopted by them
Fetal Monitoring Market Size to Reach Valuation of $4.25 Billion by 2027 | Elect …
Growth of the global fetal monitoring market is attributed to increase in incidences of stillbirths, multiple pregnancy, late maternal age, technological advancements, and increase in emphasis on continuous fetal monitoring. Furthermore, rise in investments by governments in healthcare system and hospitals are some of the factors that contribute to the growth of the market. The fetal monitoring market was valued at $2.93 billion in 2019 and is expected to reach $4.25
Fetal Monitoring Market
Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe